The utilization of competing technologies within the firm: Evidence from cardiac procedures

Management Science

Volumn 49, Issue 5, 2003, Pages 599-617

  Huckman, Robert S ^a  

^a HARVARD BUSINESS SCHOOL   (United States)

Author keywords

Competing innovation; Intrafirm groups; Technological choice; Technological status

Indexed keywords

CARDIOLOGY; DISEASES; FINANCE; PATIENT TREATMENT; PROFESSIONAL ASPECTS; SOCIETIES AND INSTITUTIONS; TECHNOLOGY;

COMPETING INNOVATION; CORONARY ARTERY DISEASE; INTRAFIRM GROUPS; TECHNOLOGICAL STATUS;

COMPETITION;

EID: 0038002650     PISSN: 00251909     EISSN: None     Source Type: Journal    
DOI: 10.1287/mnsc.49.5.599.15145     Document Type: Article

References (62)

1. Abernathy, W., K. Clark. 1985. Innovation: Mapping the winds of creative destruction. Res. Policy 14 3-22.
2. Advisory Board Company. 1997. Cardiac Surgery Renaissance: Clinical and Financial Impact of Minimally Invasive Techniques. Advisory Board Company, Washington, D.C.
3. Arthur, W. 1989. Competing technologies, increasing returns, and lock-in by historical events. Econom. J. 99 116-131.
4. Baker, L. 2001. Managed care and technology adoption in health care: Evidence from magnetic resonance imaging. J. Health Econom. 20(3) 395-421.
5. CABRI Trial Participants. 1995. First-year results of CABRI (coronary angioplasty versus bypass revascularization investigation. Lancet 346(8984) 1179-1184.
6. Chassin, M., E. Hannan, B. DeBuono. 1996. Benefits and hazards of reporting medical outcomes publicly. New England J. Medicine 334(6) 394-398.
7. Christensen, C. 1997. The Innovator's Dilemma. Harvard Business School Press, Boston, MA.
8. Cockburn, I., R. Henderson, S. Stern. 1999. The diffusion of science driven drug discovery: Organizational change in pharmaceutical research. Working paper 7359, National Bureau of Economic Research, Cambridge, MA.
9. Cohen, W., D. Levinthal. 1990. Absorptive capacity: A new perspective on learning and innovation. Admin. Sci. Quart. 35 128-152.
10. Cole, S., J. Cole. 1967. Scientific output and recognition: A study in the operation of the reward system in science. Amer. Soc. Rev. 32(3) 377-390.
11. Cutler, D., M. McClellan. 1996. The determinants of technological change in heart attack treatment. Working paper 5751, National Bureau of Economic Research, Cambridge, MA.
12. ____, ____. 2001. Is technological change in medicine worth it? Mimeograph.
13. Cyert, R., J. March. 1963. A Behavioral Theory of the Firm. Prentice-Hall, Englewood Cliffs, NJ.
14. David, P. 1985. Clio and the economics of QWERTY. Amer. Econom. Rev. 75(2) 332-337.
15. Dranove, D. 1988. Demand inducement and the physician/patient relationship. Econom. Inquiry 26(2) 281-298.
16. ____, D. Kessler, M. McClellan, M. Satterthwaite. 2002. Is more information better? The effects of "report cards" on health care providers. Working paper, National Bureau of Economic Research, 8697, Cambridge, MA.
17. Griliches, Z. 1957. Hybrid corn: An exploration in the economics of technological change. Econometrica 25(4) 501-522.
18. Hamilton, R. 1986. Hospital proposes bypass alternative. The New York Times (March 16) 14.
19. Hannan, E., H. Kilburn, M. Lindsey, R. Lewis. 1992. Clinical versus administrative data bases for CABG surgery: Does it matter? Medical Care 30(10) 892-907.
20. ____, ____, H. Bernard, J. O'Donnell, G. Lukacik, E. Shields. 1991. Coronary artery bypass graft surgery: The relationship between inhospital mortality rate and surgical volume after controlling for clinical risk factors. Medical Care 29(11) 1094-1107.
21. ____, M. Racz, T. Ryan, B. McCallister, L. Johnson, D. Arani, A. Guerci, J. Sosa, E. Topol. 1997. Coronary angioplasty volume-outcome relationships for hospitals and cardiologists. J. Amer. Medical Assoc. 277(11) 892-898.
22. Hannan, T., J. McDowell. 1984. The determinants of technology adoption: The case of the banking firm. Rand J. Econom. 15(3) 328-335.
23. Hellerstein, J. 1998. The importance of the physician in the generic versus trade-name prescription decision. Rand J. Econom. 29(1) 108-136.
24. Henderson, R., K. Clark. 1990. Architectural innovation: The reconfiguration of existing product technologies and the failure of established firms. Admin. Sci. Quart. 35 9-30.
25. Hillis, L., J. Rutherford. 1994. Coronary angioplasty compared with bypass grafting. New England J. Medicine 331(16) 1086-1087.
26. Huckman, R. 2003. The consolidation of complementary assets: An analysis of hospital acquisitions in New York state. Mimeograph, Harvard, University, Cambridge, MA
27. Information to aid in the use and interpretation of NYS cardiac data. N.d. The New York State Department of Health, Albany, NY.
28. Karlson, S. 1986. Adoption of competing inventions by United States steel producers. Rev. Econom. Statist. 68(3) 415-422.
29. Keen, B., J. Horan, C. Hanish, J. Copperstone, N. Tribbensee. 1998. Publication frequency, citation frequency, and quality of counseling psychology research. Presented at Annual Meeting of the American Psychological Association, San Francisco, CA.
30. Kessler, D., M. McClellan. 2000. Is hospital competition socially wasteful? Quart. J. Econom. 115(2) 577-615.
31. Leventis, A. 1998. Job performance and behavior: Three empirical examinations of productivity and incentive response, Mimeograph, Princeton University, Princeton, NJ.
32. Levin, S., S. Levin, J. Meisel. 1992. Market structure, uncertainty, and intrafirm diffusion: The case of optical scanners in grocery stores. Rev. Econom. Statist. 74(2) 345-350.
33. Mansfield, E. 1963. The speed of response of firms to new techniques. Quart. J. Econom. 77(2) 290-311.
34. March, J. 1962. The business firm as a political coalition. J. Politics 24(4) 662-678.
35. Mark, D., C. Nelson, R. Califf, F. Harrell, K. Lee, R. Jones, D. Fortin, R. Stack, D. Glower, L. Smith, E. DeLong, P. Smith, J. Reves, J. Jollis, J. Tcheng, L. Muhlbaier, J. Lowe, H. Phillips, D. Pryor. 1994. Continuing evolution of therapy for coronary artery disease: Initial results from the era of coronary angioplasty. Circulation 89(5) 2015-2025.
36. McClellan, M., D. Staiger. 1999. The quality of health care providers. Working paper 7327, National Bureau of Economic Research, Cambridge, MA.
37. McGuire, T., M. Pauly. 1991. Physician response to fee changes with multiple payers. J. Health Econom. 10(4) 385-410.
38. Milgrom, P., J. Roberts. 1988. An economic approach to influence activities in organizations. Amer. J. Soc. 94 S154-S179.
39. Nelson, R., S. Winter. 1982. An Evolutionary Theory of Economic Change. Harvard University Press, Cambridge, MA.
40. New York State Department of Health. 1998. Coronary artery bypass surgery in New York state: 1994-1996. Albany, NY.
41. New York State Department of Health. n.d. Information to aid in use and interpretation of NYS Cardiac data.
42. Ocasio, W. 1997. Towards an attention-based view of the firm. Strategic Management J. 18 15-30.
43. Oster, S. 1982. The diffusion of innovation among steel firms: The basic oxygen furnace. Bell J. Econom. 13 45-56.
44. Perrow, C. 1986. Complex Organizations: A Critical Essay. Random House, New York.
45. Pisano, G., R. Bohmer, A. Edmondson. 2001. Organizational differences in rates of learning: Evidence from the adoption of minimally invasive cardiac surgery. Management Sci. 47(6) 752-768.
46. Pocock, S., R. Henderson, A. Rickards, J. Hampton, S. King, C. Hamm, J. Puel, W. Hueb, J. Goy, A. Rodriguez. 1995. Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery. Lancet 346(8984) 1184-1189.
47. Podolny, J. 1993. A status-based model of market competition. Amer. J. Soc. 98(4) 829-872.
48. Podolny, J., T. Stuart. 1995. A role-based ecology of technological change. Amer. J. Soc. 100(5) 1224-1260.
49. ____, ____, M. Hannan. 1996. Networks, knowledge, and niches: Competition in the worldwide semiconductor industry. Amer. J. Soc. 102(3) 659-689.
50. Reinganum, J. 1981. Market structure and the diffusion of new technology. Bell J. Econom. 12(2) 618-624.
51. Romeo, A. 1975. Interindustry and interfirm differences in the rate of diffusion of an innovation. Rev. Econom. Statist. 57(3) 311-319.
52. Rose, N., P. Joskow. 1990. The diffusion of new technologies: Evidence from the electric utility industry. Rand J. Econom. 21(3) 354-373.
53. Rotemberg, J., G. Saloner. 1995. Overt interfunctional conflict (and its reduction through business strategy). Rand J. Econom. 26(4) 630-653.
54. Seinfeld, J., N. Mas. 2000. Is managed care restraining the adoption of technology by hospitals? Mimeograph, Harvard University, Cambridge, MA.
55. Showstack, J., K. Rosenfeld, D. Garnick, H. Luft, R. Schaffarzick, J. Fowles. 1987. Association of volume with outcome of coronary artery bypass graft surgery: Scheduled vs. nonscheduled operations. J. Amer. Medical Assoc. 257(6) 785-789.
56. Simon, H. 1947. Administrative Behavior. Free Press, New York.
57. Stern, S., M. Trajtenberg. 1998. Empirical implications of physician authority in pharmaceutical decisionmaking. Working paper 6851, National Bureau of Economic Research, Cambridge, MA.
58. Stuart, T., H. Hoang, R. Hybels. 1999. Interorganizational endorsements and the performance of entrepreneurial ventures. Admin. Sci. Quart. 44 315-349.
59. Taggart, D. 1996. Angioplasty versus bypass surgery. Lancet 347(8996) 271-272.
60. Tajtenberg, M. 1990. A penny for your quotes: Patent citations and the value of innovations. Rand J. Econom. 21(1) 172-187.
61. Tushman, M., P. Anderson. 1986. Technological discontinuities and organizational environments. Admin. Sci. Quart. 31 439-465.
62. Yip, W. 1998. Physician response to Medicare fee reductions: Changes in the volume of CABG surgeries in the Medicare and private sectors. J. Health Econom. 17 675-699.